Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring the potential cost-effectiveness and societal burden implications of screening for fracture risk in a UK general radiography setting.

BMC musculoskeletal disorders·2025

Same author

Interactions of human serum albumin with phosphate and Tris buffers: impact on paclitaxel binding and nanoparticles self-assembly.

Journal of microencapsulation·2024

Same author

A dynamical measure of the black hole mass in a quasar 11 billion years ago.

Nature·2024

Same author

Bilingualism and language in children with autistic spectrum disorder: a systematic review.

Neurologia·2023

Same author

Effectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis.

The Journal of hospital infection·2023

Same author

A dusty veil shading Betelgeuse during its Great Dimming.

Nature·2021

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Generation of RNA/DNA Hybrids in Genomic DNA by Transformation using RNA-containing Oligonucleotides

Generation of RNA/DNA Hybrids in Genomic DNA by Transformation using RNA-containing Oligonucleotides

Published on: November 24, 2010

Targeted gene correction with 5' acridine-oligonucleotide conjugates.

G de Piédoue¹, C Andrieu-Soler, J P Concordet

¹INSERM U733, Laboratoire de Thérapie Génique Hématopoïétique, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, 75010 Paris, France.

Oligonucleotides

|July 20, 2007

Summary

Acridine-conjugated single-stranded oligonucleotides (SSOs) significantly enhance gene repair efficiency by up to 10-fold. This modification improves DNA binding affinity, leading to more corrected cells for gene therapy applications.

More Related Videos

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Published on: March 16, 2022

Related Experiment Videos

Last Updated: Jul 13, 2026

Generation of RNA/DNA Hybrids in Genomic DNA by Transformation using RNA-containing Oligonucleotides

Generation of RNA/DNA Hybrids in Genomic DNA by Transformation using RNA-containing Oligonucleotides

Published on: November 24, 2010

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Published on: March 16, 2022

Area of Science:

Molecular Biology
Genetic Engineering
Biochemistry

Background:

Single-stranded oligonucleotides (SSOs) are utilized for gene repair of punctual chromosomal mutations.
The efficiency of SSO-mediated gene repair is currently limited by low frequencies of corrected cells.

Purpose of the Study:

To investigate whether enhancing the DNA binding affinity of SSOs using intercalating agents can increase gene correction efficiency.
To evaluate the impact of biochemical modifications on SSO performance in gene repair.

Main Methods:

Tested various biochemical modifications of SSOs for their gene correction capability.
Utilized a chromosomally integrated, mutated GFP reporter gene in human 293 cells.
Compared the efficacy of acridine and psoralen conjugates with nonmodified SSOs.

Main Results:

SSOs (25 nucleotides) conjugated with acridine at the 5' end increased gene correction efficiency up to 10-fold.
Acridine-modified SSOs were more effective than psoralen conjugates.
Acridine conjugation at the 3' end inhibited gene correction, while dual-sided conjugation yielded intermediate results.

Conclusions:

Enhancing SSO hybridization stability with the target DNA, particularly at the 5' end, improves gene targeting efficiency.
The findings support the 'annealing-integration' model of DNA repair.
Biochemical modification of SSOs offers a promising strategy to boost gene repair efficacy.